CS Paper Radar

Pathology Transport: Optimal-Transport Explanations for Clinical Data, and When Their Heatmaps (Fail to) Localize Disease

Lalit Kumar

cs.LG ·submitted 2026-08-18 04:59 UTC · v1
benchmark

Abstract

Generative models promise a route to explainable clinical AI: rather than probe a classifier, model the distributions of healthy and diseased patients and read explanations off the geometry between them. We build such a system - an optimal-transport rectified flow trained between two clinical distributions - and use it to ask a pointed question the field too rarely tests: do the resulting explanation heatmaps actually localize disease? On tabular tumour biomarkers (Breast Cancer Wisconsin) a single flow yields per-patient counterfactuals, an unsupervised malignancy score (AUROC 0.91; 0.93 +/- 0.01 across five seeds), and a label-free attribution that agrees with a supervised classifier (r ~ 0.5) - a compact, honest interpretability engine, though it never out-predicts logistic regression. Moving to chest X-rays, we show the transport heatmap is a population-level signal, not a localiser; a reconstruction-based, identity-preserving variant does localize synthetic lesions (pointing game 0.52), yet on real RSNA radiologist boxes it collapses to chance while only supervised Grad-CAM stays above it. The central result is a synthetic-to-real gap: label-free heatmaps that look compelling on planted lesions are not evidence of real localisation. We contribute a reusable optimal-transport recipe for generative explanations and a controlled benchmark for stress-testing whether they localize.

Closest papers

Nearest neighbours by meaning across the whole index.

Evidence-Bound Reasoning: Neuro-Semantic Verification of Biomedical AI in Glioblastoma Radiogenomics

cs.CL ·2026-10-06 ·Mariya Miteva, Maria Nisheva-Pavlova
benchmark similarity 0.64
Abstract · 15 pages, 4 figures, 4 tables. Preprint

Background: Biomedical AI can generate plausible explanations without reliably verifying whether each statement is supported by patient-specific evidence. We developed a neuro-semantic verification framework that converts radiomic measurements into addressable evidence records and machine-checkable claims. Methods: UPenn-GBM radiomics were aligned with de novo CaPTk extraction from standardized MRI and expert-validated segmentations in an independent multicenter cohort. The shared space comprised 1,728 features from T1, T1GD, T2, and FLAIR MRI across three tumor regions. Reference-defined semantic states were derived from 611 UPenn cases. We evaluated cross-cohort transportability, model-linked provenance, deterministic verification, controlled predictive degradation, and an LLM claim-extraction pilot; MGMT prediction served only as a transport stress test. Results: Median semantic-state agreement was 0.786 (weighted kappa 0.709), ranging from 0.918 for morphologic to 0.252 for intensity features. The external evidence ledger contained 1,655 model-linked records for 331 patients. The verifier achieved 100% exact-set accuracy in a 6,620-claim corruption benchmark. In a 24-case pilot, GPT-5.6 Sol reproduced 72/72 prespecified atomic claims, and the frozen verifier recovered 24/24 expected conditions. During controlled degradation, ROC AUC declined from 0.899 to 0.500 while verification accuracy remained 1.000. External MGMT discrimination was weak (ROC AUC 0.543). Conclusions: Verifiability can be engineered and evaluated independently of predictive performance. LLMs may structure explanations, while final evidence-consistency checking remains deterministic.

0.23

Evidence-Driven Differential Diagnosis of Malignant Melanoma

eess.IV cs.AIcs.CVcs.LG ·2026-08-28 ·Naren Akash, Anirudh Kaushik, Jayanthi Sivaswamy
top venuecode/data similarity 0.64
Abstract

We present a modular and multi-level framework for the differential diagnosis of malignant melanoma. Our framework integrates contextual information and evidence at the lesion, patient, and population levels, enabling decision-making at each level. We introduce an anatomic-site aware masked transformer, which effectively models the patient context by considering all lesions in a patient, which can be variable in count, and their site of incidence. Additionally, we incorporate patient metadata via learnable demographics embeddings to capture population statistics. Through extensive experiments, we explore the influence of specific information on the decision-making process and examine the tradeoff in metrics when considering different types of information. Validation results using the SIIM-ISIC 2020 dataset indicate including the lesion context with location and metadata improves specificity by 17.15% and 7.14%, respectively, while enhancing balanced accuracy. The code is available at https://github.com/narenakash/meldd.

0.69

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.64
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

Reading the Mask: Descriptor-Grounded BI-RADS Rationale Generation for Breast MRI Segmentation

cs.CV cs.AI ·2026-10-21 ·Hrishikesh Singh, Aarti Sharma, Divyanshu Kumar, Millie Pant
similarity 0.64
Abstract

Deep learning based models accurately delineate tumours on dynamic contrast-enhanced MRI (DCE-MRI), but segmentation masks alone do not provide the rationales or reasoning used by radiologists to assess the lesion suspicion. This limits the explainability as well the clinical integration. We investigate whether clinically relevant descriptors can instead be derived from the segmentation masks and their dynamic contrast-enhancement series. We have used Breast Imaging Reporting and Data System (BI-RADS) guidelines as a structured framework. Using these guidelines we designed a BI-RADS decision tree with eight quantitative measurements using radiomics, together with the lesion size and component count, that determine the descriptors at eight nodes. Using these descriptors we generate natural-language rationale using a large language model. The model was constrained to express only the derived records from the decision tree. After applying this framework to the expert and automatic masks of each of the 1,506 cases in the MAMA-MIA dataset, we generated a reproducible corpus of 3,012 BI-RADS grounded rationales. We obtained a faithfulness score of 99.98% and a counterfactual accuracy of 99.3%, indicating that the generated rationales faithfully verbalises the measured descriptors and correctly reflects changes in the underlying record. Agreement between the descriptors from expert and automatic masks falls from 0.832 to 0.549 as mask quality falls from Good to Missed. The generated rationales are intended as draft representations for radiologist review and final sign-off rather than autonomous clinical reports.

0.13

SCALE: Towards whole-slide counterfactual explanations in pathology

cs.CV ·2026-11-10 ·Weiyi Qin, Yingci Liu-Swetz, Shiwei Tan, Yi Wang, Mohammad Alexanderani +9 more
similarity 0.64
Abstract

Cancer diagnosis relies on histopathological evaluation, where tumor morphology guides disease classification and informs treatment decisions. Deep learning (DL) models excel at predicting diagnostic properties from histopathology images. Unlike typical medical images featuring small critical areas, histopathological images are textural, with relevant texture spanning the entire image; this makes it challenging to explain DL predictions by locating relevant image regions. Counterfactual explanations offer a promising alternative by asking "what changes in the image could have altered the model prediction." To achieve this, we propose SCALE, a framework for generating such counterfactual explanations for histopathological DL models. Across nine counterfactual directions spanning multiple cancer types, SCALE generates whole-slide counterfactual explanations that consistently shift predictions toward the intended target while maintaining biological feasibility. Blinded assessment by six board-certified pathologists showed higher morphological plausibility for SCALE (with a win rate of 91.7% over baselines) and promising counterfactual effectiveness (with a target consistency of 96.7%).

0.18

Transcriptome-informed multi-modal AI for predicting neoadjuvant therapy response from breast cancer biopsies

cs.AI ·2026-10-02 ·Jungkyu Park, Dhruva Biswas, Joseph Cappadona, Cerise Tang, Ken G. Zeng +20 more
similarity 0.63
Abstract

Scarcity of labeled data limits development of deep learning biomarkers in oncology. We develop a two-stage AI model predicting pathological complete response (pCR) to neoadjuvant therapy in breast cancer. The first stage learns the transcriptome from histopathology using 8,742 patients across 32 cancer types, corroborated by pathologist review and spatial agreement with measured expression. This simplifies the second stage to predicting pCR from inferred expression and clinical variables. Developed using 1,080 patients (five cohorts) and evaluated in 1,412 patients (nine cohorts), the model achieves a pooled AUROC of 0.79 (95% CI, 0.73-0.85), discriminating responders within molecular subtypes. It outperforms histopathological biomarkers, remaining stable across intratumoral sampling and with minimal biopsy tissue. Ablations show transcriptome-wide inference improves discrimination over clinical variables alone or one-stage pathology models, and robustness by avoiding genomic assays' gene selection constraints. These results indicate that biologically informed compression may generalize to data-sparse applications in precision oncology.

0.06

A radiographic world model for clinical reasoning and evidence generation

cs.AI ·2026-09-07 ·Suyang Xi, Songtao Hu, Shansong Wang, Mojtaba Safari, Luke del Balzo +6 more
highly cited similarity 0.63
Abstract

Medical imaging artificial intelligence (AI) is commonly developed as separate mappings from radiographs to diagnostic outputs or from clinical descriptions to generated images, although both arise from the same underlying radiographic state. A world-model formulation instead seeks to learn an internal representation of this state that can support both clinical readout and conditional simulation of radiographic observations. Here we introduce MedDream, a radiographic world model that learns a shared continuous latent state from paired chest radiograph-text observations for diagnostic reasoning and report-conditioned evidence generation. MedDream was pretrained on 2.65 million leakage-controlled chest radiograph-text pairs curated from 4.40 million candidates. Across eight clinical datasets and two independent reader cohorts, MedDream outperformed leading diagnostic and generative comparators. For diagnostic reasoning, MedDream showed strong generalization across disease recognition, label-scarce adaptation, severity assessment, and localization, while MedDream-supported review increased mean resident concordance with independent radiologist consensus from 56.3% to 63.0%. For evidence generation, MedDream produced radiographs that preserved clinically relevant pathology and improved downstream performance on held-out real data, with synthetic augmentation increasing external VinDr-CXR macro-AUROC from 76.4% to 81.4%. More importantly, conditioning generation on prespecified subgroup performance gaps enabled targeted evidence construction, increasing weighted F1 by 3.1 percentage points in Asian patients, whereas matched-volume unguided augmentation decreased it by 2.3 points. These findings establish radiographic world models as a path toward medical AI that learns clinically meaningful internal states for interpreting, simulating, and constructing evidence for clinical use.

0.36

Glyph: An Interpretability Engine for AI-Driven Scientific Discovery in Clinical Data

cs.AI ·2026-11-06 ·Robbie Holland, Ashwin Kumar, Mateus A. Esmeraldo, David Le, Andrea Fisher +17 more
code/data similarity 0.62
Abstract

Automated scientific discovery has the potential to advance understanding of disease mechanisms and accelerate identification of early disease markers. Manual data annotation is infeasible at population scale, motivating methods that automatically extract pre-defined phenotypes in multimodal and unstructured clinical data. Such pre-defined feature sets determine and limit which associations these approaches can discover. This limitation extends to agentic AI systems that use these tools to query population-scale data. In contrast, foundation models (FMs) trained on large volumes of clinical data can perform tasks beyond their training objectives. This suggests their latent embeddings may represent novel or unexplored features that could yield insights into disease mechanisms, yet such latent features remain difficult to interpret. To address this challenge, we introduce Glyph, an automated multistage framework that extracts features from multimodal and unstructured clinical data using FMs and sparse autoencoders, interprets them as coded clinical concepts, and evaluates their value for clinical scientific discovery. We applied Glyph to abdominal CT volumes, CT radiology reports and laboratory measurements from 41,628 patients across different institutions. We identified 397 predictive concepts supported by 4,463 Bonferroni-significant associations. Moreover, a majority of discovered associations were automatically reproducible in held-out cohorts across different sites. Glyph concepts provided complementary associations to literature-derived markers, leading to gains in predictive power. We envision that interpretability can extend beyond a mechanistic understanding of neural networks to connecting implicitly learned features with clinical knowledge and establishing their significance for patient outcomes. We release Glyph at https://github.com/StanfordMIMI/Glyph.

0.40